 | • レポートコード：QFJ1-5721 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、デュロキセチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（20mgカプセル、30mgカプセル、40mgカプセル、60mgカプセル）、用途別市場規模（病院、ドラックストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・デュロキセチンの市場動向 ・企業の競争状況、市場シェア ・デュロキセチンの種類別市場規模と予測2016-2027（20mgカプセル、30mgカプセル、40mgカプセル、60mgカプセル） ・デュロキセチンの用途別市場規模と予測2016-2027（病院、ドラックストア） ・デュロキセチンの北米市場規模2016-2027（アメリカ、カナダ） ・デュロキセチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・デュロキセチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・デュロキセチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・デュロキセチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Teva、Lupin、Sun Pharma、Zydus Pharmaceuticals、Torrent Pharmaceuticals、Sandoz、Aurobindo Pharma、Apotex、Breckenridge、MACLEODS、Ajanta Pharma、CSPC Ouyi Pharm、Jiangsu Nhwa Pharmaceutical） ・結論 |
Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain.
Market Analysis and Insights: Global Duloxetine Market
The global Duloxetine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Duloxetine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Duloxetine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Duloxetine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Duloxetine market.
Global Duloxetine Scope and Market Size
Duloxetine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Duloxetine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
20mg Capsules
30mg Capsules
40mg Capsules
60mg Capsules
Segment by Application
Hospital
Drug store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly
Teva
Lupin
Sun Pharma
Zydus Pharmaceuticals
Torrent Pharmaceuticals
Sandoz
Aurobindo Pharma
Apotex
Breckenridge
MACLEODS
Ajanta Pharma
CSPC Ouyi Pharm
Jiangsu Nhwa Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Duloxetine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 20mg Capsules
1.2.3 30mg Capsules
1.2.4 40mg Capsules
1.2.5 60mg Capsules
1.3 Market by Application
1.3.1 Global Duloxetine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Duloxetine Market Perspective (2016-2027)
2.2 Duloxetine Growth Trends by Regions
2.2.1 Duloxetine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Duloxetine Historic Market Share by Regions (2016-2021)
2.2.3 Duloxetine Forecasted Market Size by Regions (2022-2027)
2.3 Duloxetine Industry Dynamic
2.3.1 Duloxetine Market Trends
2.3.2 Duloxetine Market Drivers
2.3.3 Duloxetine Market Challenges
2.3.4 Duloxetine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Duloxetine Players by Revenue
3.1.1 Global Top Duloxetine Players by Revenue (2016-2021)
3.1.2 Global Duloxetine Revenue Market Share by Players (2016-2021)
3.2 Global Duloxetine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Duloxetine Revenue
3.4 Global Duloxetine Market Concentration Ratio
3.4.1 Global Duloxetine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Duloxetine Revenue in 2020
3.5 Duloxetine Key Players Head office and Area Served
3.6 Key Players Duloxetine Product Solution and Service
3.7 Date of Enter into Duloxetine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Duloxetine Breakdown Data by Type
4.1 Global Duloxetine Historic Market Size by Type (2016-2021)
4.2 Global Duloxetine Forecasted Market Size by Type (2022-2027)
5 Duloxetine Breakdown Data by Application
5.1 Global Duloxetine Historic Market Size by Application (2016-2021)
5.2 Global Duloxetine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Duloxetine Market Size (2016-2027)
6.2 North America Duloxetine Market Size by Type
6.2.1 North America Duloxetine Market Size by Type (2016-2021)
6.2.2 North America Duloxetine Market Size by Type (2022-2027)
6.2.3 North America Duloxetine Market Size by Type (2016-2027)
6.3 North America Duloxetine Market Size by Application
6.3.1 North America Duloxetine Market Size by Application (2016-2021)
6.3.2 North America Duloxetine Market Size by Application (2022-2027)
6.3.3 North America Duloxetine Market Size by Application (2016-2027)
6.4 North America Duloxetine Market Size by Country
6.4.1 North America Duloxetine Market Size by Country (2016-2021)
6.4.2 North America Duloxetine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Duloxetine Market Size (2016-2027)
7.2 Europe Duloxetine Market Size by Type
7.2.1 Europe Duloxetine Market Size by Type (2016-2021)
7.2.2 Europe Duloxetine Market Size by Type (2022-2027)
7.2.3 Europe Duloxetine Market Size by Type (2016-2027)
7.3 Europe Duloxetine Market Size by Application
7.3.1 Europe Duloxetine Market Size by Application (2016-2021)
7.3.2 Europe Duloxetine Market Size by Application (2022-2027)
7.3.3 Europe Duloxetine Market Size by Application (2016-2027)
7.4 Europe Duloxetine Market Size by Country
7.4.1 Europe Duloxetine Market Size by Country (2016-2021)
7.4.2 Europe Duloxetine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Duloxetine Market Size (2016-2027)
8.2 Asia-Pacific Duloxetine Market Size by Type
8.2.1 Asia-Pacific Duloxetine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Duloxetine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Duloxetine Market Size by Type (2016-2027)
8.3 Asia-Pacific Duloxetine Market Size by Application
8.3.1 Asia-Pacific Duloxetine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Duloxetine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Duloxetine Market Size by Application (2016-2027)
8.4 Asia-Pacific Duloxetine Market Size by Region
8.4.1 Asia-Pacific Duloxetine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Duloxetine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Duloxetine Market Size (2016-2027)
9.2 Latin America Duloxetine Market Size by Type
9.2.1 Latin America Duloxetine Market Size by Type (2016-2021)
9.2.2 Latin America Duloxetine Market Size by Type (2022-2027)
9.2.3 Latin America Duloxetine Market Size by Type (2016-2027)
9.3 Latin America Duloxetine Market Size by Application
9.3.1 Latin America Duloxetine Market Size by Application (2016-2021)
9.3.2 Latin America Duloxetine Market Size by Application (2022-2027)
9.3.3 Latin America Duloxetine Market Size by Application (2016-2027)
9.4 Latin America Duloxetine Market Size by Country
9.4.1 Latin America Duloxetine Market Size by Country (2016-2021)
9.4.2 Latin America Duloxetine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Duloxetine Market Size (2016-2027)
10.2 Middle East & Africa Duloxetine Market Size by Type
10.2.1 Middle East & Africa Duloxetine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Duloxetine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Duloxetine Market Size by Type (2016-2027)
10.3 Middle East & Africa Duloxetine Market Size by Application
10.3.1 Middle East & Africa Duloxetine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Duloxetine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Duloxetine Market Size by Application (2016-2027)
10.4 Middle East & Africa Duloxetine Market Size by Country
10.4.1 Middle East & Africa Duloxetine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Duloxetine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Duloxetine Introduction
11.1.4 Eli Lilly Revenue in Duloxetine Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Duloxetine Introduction
11.2.4 Teva Revenue in Duloxetine Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Lupin
11.3.1 Lupin Company Details
11.3.2 Lupin Business Overview
11.3.3 Lupin Duloxetine Introduction
11.3.4 Lupin Revenue in Duloxetine Business (2016-2021)
11.3.5 Lupin Recent Development
11.4 Sun Pharma
11.4.1 Sun Pharma Company Details
11.4.2 Sun Pharma Business Overview
11.4.3 Sun Pharma Duloxetine Introduction
11.4.4 Sun Pharma Revenue in Duloxetine Business (2016-2021)
11.4.5 Sun Pharma Recent Development
11.5 Zydus Pharmaceuticals
11.5.1 Zydus Pharmaceuticals Company Details
11.5.2 Zydus Pharmaceuticals Business Overview
11.5.3 Zydus Pharmaceuticals Duloxetine Introduction
11.5.4 Zydus Pharmaceuticals Revenue in Duloxetine Business (2016-2021)
11.5.5 Zydus Pharmaceuticals Recent Development
11.6 Torrent Pharmaceuticals
11.6.1 Torrent Pharmaceuticals Company Details
11.6.2 Torrent Pharmaceuticals Business Overview
11.6.3 Torrent Pharmaceuticals Duloxetine Introduction
11.6.4 Torrent Pharmaceuticals Revenue in Duloxetine Business (2016-2021)
11.6.5 Torrent Pharmaceuticals Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Details
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Duloxetine Introduction
11.7.4 Sandoz Revenue in Duloxetine Business (2016-2021)
11.7.5 Sandoz Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Details
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Duloxetine Introduction
11.8.4 Aurobindo Pharma Revenue in Duloxetine Business (2016-2021)
11.8.5 Aurobindo Pharma Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Apotex Business Overview
11.9.3 Apotex Duloxetine Introduction
11.9.4 Apotex Revenue in Duloxetine Business (2016-2021)
11.9.5 Apotex Recent Development
11.10 Breckenridge
11.10.1 Breckenridge Company Details
11.10.2 Breckenridge Business Overview
11.10.3 Breckenridge Duloxetine Introduction
11.10.4 Breckenridge Revenue in Duloxetine Business (2016-2021)
11.10.5 Breckenridge Recent Development
11.11 MACLEODS
11.11.1 MACLEODS Company Details
11.11.2 MACLEODS Business Overview
11.11.3 MACLEODS Duloxetine Introduction
11.11.4 MACLEODS Revenue in Duloxetine Business (2016-2021)
11.11.5 MACLEODS Recent Development
11.12 Ajanta Pharma
11.12.1 Ajanta Pharma Company Details
11.12.2 Ajanta Pharma Business Overview
11.12.3 Ajanta Pharma Duloxetine Introduction
11.12.4 Ajanta Pharma Revenue in Duloxetine Business (2016-2021)
11.12.5 Ajanta Pharma Recent Development
11.13 CSPC Ouyi Pharm
11.13.1 CSPC Ouyi Pharm Company Details
11.13.2 CSPC Ouyi Pharm Business Overview
11.13.3 CSPC Ouyi Pharm Duloxetine Introduction
11.13.4 CSPC Ouyi Pharm Revenue in Duloxetine Business (2016-2021)
11.13.5 CSPC Ouyi Pharm Recent Development
11.14 Jiangsu Nhwa Pharmaceutical
11.14.1 Jiangsu Nhwa Pharmaceutical Company Details
11.14.2 Jiangsu Nhwa Pharmaceutical Business Overview
11.14.3 Jiangsu Nhwa Pharmaceutical Duloxetine Introduction
11.14.4 Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2016-2021)
11.14.5 Jiangsu Nhwa Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Duloxetine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 20mg Capsules
Table 3. Key Players of 30mg Capsules
Table 4. Key Players of 40mg Capsules
Table 5. Key Players of 60mg Capsules
Table 6. Global Duloxetine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Duloxetine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Duloxetine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Duloxetine Market Share by Regions (2016-2021)
Table 10. Global Duloxetine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Duloxetine Market Share by Regions (2022-2027)
Table 12. Duloxetine Market Trends
Table 13. Duloxetine Market Drivers
Table 14. Duloxetine Market Challenges
Table 15. Duloxetine Market Restraints
Table 16. Global Duloxetine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Duloxetine Market Share by Players (2016-2021)
Table 18. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duloxetine as of 2020)
Table 19. Ranking of Global Top Duloxetine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Duloxetine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Duloxetine Product Solution and Service
Table 23. Date of Enter into Duloxetine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Duloxetine Revenue Market Share by Type (2016-2021)
Table 27. Global Duloxetine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Duloxetine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Duloxetine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Duloxetine Revenue Market Share by Application (2016-2021)
Table 31. Global Duloxetine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Duloxetine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Duloxetine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Duloxetine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Duloxetine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Duloxetine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Duloxetine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Duloxetine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Duloxetine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Duloxetine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Duloxetine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Duloxetine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Duloxetine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Duloxetine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Duloxetine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Duloxetine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Duloxetine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Duloxetine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Duloxetine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Duloxetine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Duloxetine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Duloxetine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Duloxetine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Duloxetine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Duloxetine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Duloxetine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Duloxetine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Duloxetine Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Duloxetine Product
Table 66. Eli Lilly Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Teva Company Details
Table 69. Teva Business Overview
Table 70. Teva Duloxetine Product
Table 71. Teva Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 72. Teva Recent Development
Table 73. Lupin Company Details
Table 74. Lupin Business Overview
Table 75. Lupin Duloxetine Product
Table 76. Lupin Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 77. Lupin Recent Development
Table 78. Sun Pharma Company Details
Table 79. Sun Pharma Business Overview
Table 80. Sun Pharma Duloxetine Product
Table 81. Sun Pharma Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 82. Sun Pharma Recent Development
Table 83. Zydus Pharmaceuticals Company Details
Table 84. Zydus Pharmaceuticals Business Overview
Table 85. Zydus Pharmaceuticals Duloxetine Product
Table 86. Zydus Pharmaceuticals Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 87. Zydus Pharmaceuticals Recent Development
Table 88. Torrent Pharmaceuticals Company Details
Table 89. Torrent Pharmaceuticals Business Overview
Table 90. Torrent Pharmaceuticals Duloxetine Product
Table 91. Torrent Pharmaceuticals Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 92. Torrent Pharmaceuticals Recent Development
Table 93. Sandoz Company Details
Table 94. Sandoz Business Overview
Table 95. Sandoz Duloxetine Product
Table 96. Sandoz Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 97. Sandoz Recent Development
Table 98. Aurobindo Pharma Company Details
Table 99. Aurobindo Pharma Business Overview
Table 100. Aurobindo Pharma Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 101. Aurobindo Pharma Recent Development
Table 102. Apotex Company Details
Table 103. Apotex Business Overview
Table 104. Apotex Duloxetine Product
Table 105. Apotex Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 106. Apotex Recent Development
Table 107. Breckenridge Company Details
Table 108. Breckenridge Business Overview
Table 109. Breckenridge Duloxetine Product
Table 110. Breckenridge Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 111. Breckenridge Recent Development
Table 112. MACLEODS Company Details
Table 113. MACLEODS Business Overview
Table 114. MACLEODS Duloxetine Product
Table 115. MACLEODS Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 116. MACLEODS Recent Development
Table 117. Ajanta Pharma Company Details
Table 118. Ajanta Pharma Business Overview
Table 119. Ajanta Pharma Duloxetine Product
Table 120. Ajanta Pharma Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 121. Ajanta Pharma Recent Development
Table 122. CSPC Ouyi Pharm Company Details
Table 123. CSPC Ouyi Pharm Business Overview
Table 124. CSPC Ouyi Pharm Duloxetine Product
Table 125. CSPC Ouyi Pharm Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 126. CSPC Ouyi Pharm Recent Development
Table 127. Jiangsu Nhwa Pharmaceutical Company Details
Table 128. Jiangsu Nhwa Pharmaceutical Business Overview
Table 129. Jiangsu Nhwa Pharmaceutical Duloxetine Product
Table 130. Jiangsu Nhwa Pharmaceutical Revenue in Duloxetine Business (2016-2021) & (US$ Million)
Table 131. Jiangsu Nhwa Pharmaceutical Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Duloxetine Market Share by Type: 2020 VS 2027
Figure 2. 20mg Capsules Features
Figure 3. 30mg Capsules Features
Figure 4. 40mg Capsules Features
Figure 5. 60mg Capsules Features
Figure 6. Global Duloxetine Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Duloxetine Report Years Considered
Figure 10. Global Duloxetine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Duloxetine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Duloxetine Market Share by Regions: 2020 VS 2027
Figure 13. Global Duloxetine Market Share by Regions (2022-2027)
Figure 14. Global Duloxetine Market Share by Players in 2020
Figure 15. Global Top Duloxetine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Duloxetine as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Duloxetine Revenue in 2020
Figure 17. Global Duloxetine Revenue Market Share by Type (2016-2021)
Figure 18. Global Duloxetine Revenue Market Share by Type (2022-2027)
Figure 19. North America Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Duloxetine Market Share by Type (2016-2027)
Figure 21. North America Duloxetine Market Share by Application (2016-2027)
Figure 22. North America Duloxetine Market Share by Country (2016-2027)
Figure 23. United States Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Duloxetine Market Share by Type (2016-2027)
Figure 27. Europe Duloxetine Market Share by Application (2016-2027)
Figure 28. Europe Duloxetine Market Share by Country (2016-2027)
Figure 29. Germany Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Duloxetine Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Duloxetine Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Duloxetine Market Share by Region (2016-2027)
Figure 39. China Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Duloxetine Market Share by Type (2016-2027)
Figure 47. Latin America Duloxetine Market Share by Application (2016-2027)
Figure 48. Latin America Duloxetine Market Share by Country (2016-2027)
Figure 49. Mexico Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Duloxetine Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Duloxetine Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Duloxetine Market Share by Country (2016-2027)
Figure 55. Turkey Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Duloxetine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 59. Teva Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 60. Lupin Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 61. Sun Pharma Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 62. Zydus Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 63. Torrent Pharmaceuticals Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 64. Sandoz Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 65. Aurobindo Pharma Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 66. Apotex Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 67. Breckenridge Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 68. MACLEODS Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 69. Ajanta Pharma Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 70. CSPC Ouyi Pharm Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 71. Jiangsu Nhwa Pharmaceutical Revenue Growth Rate in Duloxetine Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のデュロキセチン医薬品有効成分（API）産業調査2019-2025 Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical formulations. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Moreover, it is used to help relieve neuropathic pain in people with diabetes or ongoing…- 世界のデュロキセチン医薬品有効成分（API）産業調査2019-2025 Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical formulations. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Moreover, it is used to help relieve neuropathic pain in people with diabetes or ongoing…
- 腸溶性空カプセルのグローバル市場2021 Enteric Empty Capsules is a niche type of empty capsules that can prevent the material inside destroyed in gastric area. This report includes the estimation of market size for value (million USD) and volume (M Capsules). Both top-down and bottom-up approaches have been used to estimate and validate …
- ベジタリアンソフトジェルカプセルのグローバル市場2021 Vegetarian Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both. Vegetarian Softgels are all-natural, GMO free, plant-based shell, free from anima…
- 世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…